GB1437138A - Method of increasing sexual potency - Google Patents

Method of increasing sexual potency

Info

Publication number
GB1437138A
GB1437138A GB3231673A GB3231673A GB1437138A GB 1437138 A GB1437138 A GB 1437138A GB 3231673 A GB3231673 A GB 3231673A GB 3231673 A GB3231673 A GB 3231673A GB 1437138 A GB1437138 A GB 1437138A
Authority
GB
United Kingdom
Prior art keywords
sexual potency
increasing sexual
july
potency
oxytocin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3231673A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB1437138A publication Critical patent/GB1437138A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1437138 Increasing sexual potency SANDOZ Ltd 6 July 1973 [10 July 1972 25 Oct 1972] 32316/73 Heading A5B Sexual potency in the human male is increased (other than in the treatment or prevention of disease) by administering oxytocin or desamino oxytocin either orally, e.g. as buccal or oral tablets, or parenterally.
GB3231673A 1972-07-10 1973-07-06 Method of increasing sexual potency Expired GB1437138A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1030372 1972-07-10
CH1561872 1972-10-25

Publications (1)

Publication Number Publication Date
GB1437138A true GB1437138A (en) 1976-05-26

Family

ID=25706319

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3231673A Expired GB1437138A (en) 1972-07-10 1973-07-06 Method of increasing sexual potency

Country Status (4)

Country Link
AU (1) AU5794973A (en)
DE (1) DE2334358A1 (en)
GB (1) GB1437138A (en)
NL (1) NL7309392A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003204720B2 (en) * 1998-05-29 2006-06-29 Tap Pharmaceutical Products Inc. Methods for the normalization of sexual response and amelioration of long term genital tissue degradation
WO2016053092A1 (en) * 2014-10-01 2016-04-07 Oxytone Bioscience B.V. Orally disintegrating solid pharmaceutical dosage unit containing a partus control substance
US10172913B2 (en) 2014-10-01 2019-01-08 Oxytone Bioscience B.V. Orally disintegrating solid pharmaceutical dosage unit containing a partus control substance

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4229880A1 (en) * 1992-09-04 1994-03-31 Knauf Siegfried Medicaments contg. oxytocin, vasopressin and/or endorphins - for treating sex crime, bed-wetting, autism, homosexulaity and bulimia

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003204720B2 (en) * 1998-05-29 2006-06-29 Tap Pharmaceutical Products Inc. Methods for the normalization of sexual response and amelioration of long term genital tissue degradation
WO2016053092A1 (en) * 2014-10-01 2016-04-07 Oxytone Bioscience B.V. Orally disintegrating solid pharmaceutical dosage unit containing a partus control substance
US10172913B2 (en) 2014-10-01 2019-01-08 Oxytone Bioscience B.V. Orally disintegrating solid pharmaceutical dosage unit containing a partus control substance
US10525099B2 (en) 2014-10-01 2020-01-07 Oxytone Bioscience B.V. Orally disintegrating solid pharmaceutical dosage unit containing a partus control substance

Also Published As

Publication number Publication date
AU5794973A (en) 1975-01-16
NL7309392A (en) 1974-01-14
DE2334358A1 (en) 1974-01-24

Similar Documents

Publication Publication Date Title
GR76810B (en)
ES2186787T3 (en) USE OF RITONAVIR (ABT-538) TO IMPROVE THE PHARMACOCINETICS OF MEDICINES METABOLIZED BY THE CYCROCHROME P450 IN A METHOD OF TREATMENT OF AIDS.
OA08581A (en) Treatment of diseases caused by retroviruses.
GB1380171A (en) Medicinal tablets
ES352030A1 (en) Urate oxidase and process for the production thereof
GB1388358A (en) Taste-improving formulations of oral penicillins
GB1437138A (en) Method of increasing sexual potency
EP0093497A3 (en) Anthelmintic treatment
JPS51128438A (en) An antibacterial drug against fish diseases
GB1118606A (en) Compositions for the treatment of haemorrhoids
CA953294A (en) Preparation of 3'-4'-dideoxykanamycin b active against resistant bacteria
GB1143061A (en) Improvements in or relating to compositions affecting learning and retention
JPS57159715A (en) Synergism of analgesic
BE900089A (en) USE OF MINI-SOMATOSTATINS IN THERAPEUTICS.
DE69428797D1 (en) USE OF BENZYDAMINE TO TREAT DISEASES CAUSED BY TNF
SU1069818A1 (en) Method of prophylaxis of influenza
GB1323008A (en) Alkoxybenzoyl-alkanoic acids and their uses
GB1257264A (en)
GB1224658A (en) Cyclic decapeptides
GB976096A (en) Pharmaceutical compositions
FR2088218A1 (en) Lactulose-cytochrome c compsns - treatment of nephropathic acidosis and auto-toxic states
FR2092649A1 (en) Oral antirheumatic compsn - of aceylsalicylic acid magnesium thiomalate, thiamine and ascorbic acid
GB1316006A (en) Pharmaceutically active chemical compound and an antitumourigenic preparation containing same
FR2646348B1 (en)
GB1422745A (en) Pharmaceutical compositions containing 4-hydroxy- 1,23-benzotriazine and methods of using same

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees